[
    [
        {
            "time": "2021-12-16",
            "original_text": "【民生医药|周报】12/16：关注特色原料药和CXO板块，积极布局优势赛道",
            "features": {
                "keywords": [
                    "民生医药",
                    "周报",
                    "特色原料药",
                    "CXO板块",
                    "优势赛道"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【民生医药|周报】12/16：关注特色原料药和CXO板块，积极布局优势赛道",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-03-09",
            "original_text": "Wellington Management Group LLP减持药明康德(02359)23.77万股，每股作价96.37港元 减持股份",
            "features": {
                "keywords": [
                    "Wellington Management Group LLP",
                    "减持",
                    "药明康德",
                    "23.77万股",
                    "96.37港元"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Wellington Management Group LLP减持药明康德(02359)23.77万股，每股作价96.37港元 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2022-03-09",
            "original_text": "【权益变动】药明康德(02359-HK)被WellingtonMgt减持23.77万股 减持股份",
            "features": {
                "keywords": [
                    "权益变动",
                    "药明康德",
                    "WellingtonMgt",
                    "减持",
                    "23.77万股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【权益变动】药明康德(02359-HK)被WellingtonMgt减持23.77万股 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]